Found: 87
Select item for more details and to access through your institution.
Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing.
- Published in:
- Clinical Pharmacology & Therapeutics, 2011, v. 89, n. 3, p. 387, doi. 10.1038/clpt.2010.320
- By:
- Publication type:
- Article
Pediatric "PSC-IBD": a descriptive report of associated inflammatory bowel disease among pediatric patients with psc.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Antineutrophil cytoplasmic antibody subtypes in children and adolescents after ileal pouch-anal anastomosis for ulcerative colitis.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Measurement of colonic tissue cyclosporine concentration in children with severe ulcerative colitis.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis: a case-control study.
- Published in:
- 1998
- By:
- Publication type:
- journal article
A17 EFFICACY AND SAFETY OF FILGOTINIB AS MAINTENANCE THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. 21, doi. 10.1093/jcag/gwab002.016
- By:
- Publication type:
- Article
A15 EFFICACY AND SAFETY OF FILGOTINIB AS INDUCTION THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2021, v. 4, p. 18, doi. 10.1093/jcag/gwab002.014
- By:
- Publication type:
- Article
A202 TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 5.4 YEARS OF SAFETY DATA FROM GLOBAL CLINICAL TRIALS.
- Published in:
- Journal of the Canadian Association of Gastroenterology, 2019, v. 2, p. 396, doi. 10.1093/jcag/gwz006.201
- By:
- Publication type:
- Article
What's new: innovative concepts in inflammatory bowel disease.
- Published in:
- Colorectal Disease, 2006, v. 8, p. 3, doi. 10.1111/j.1463-1318.2006.00985.x
- By:
- Publication type:
- Article
Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update.
- Published in:
- Clinical Pharmacology & Therapeutics, 2013, v. 93, n. 4, p. 324, doi. 10.1038/clpt.2013.4
- By:
- Publication type:
- Article
Anti-TNF Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacokinetics-Based Dosing Paradigms.
- Published in:
- Clinical Pharmacology & Therapeutics, 2012, v. 91, n. 4, p. 635, doi. 10.1038/clpt.2011.328
- By:
- Publication type:
- Article
Total laparoscopic proctocolectomy with Brooke ileostomy.
- Published in:
- Surgical Endoscopy & Other Interventional Techniques, 2005, v. 19, n. 9, p. 1284, doi. 10.1007/s00464-004-8245-y
- By:
- Publication type:
- Article
Medical management of mild to moderate Crohn’s disease: evidence-based treatment algorithms for induction and maintenance of remission.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2007, v. 26, n. 7, p. 987, doi. 10.1111/j.1365-2036.2007.03455.x
- By:
- Publication type:
- Article
MMX Multi Matrix System<sup>®</sup> mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2007, v. 26, n. 2, p. 205, doi. 10.1111/j.1365-2036.2007.03361.x
- By:
- Publication type:
- Article
Age at onset of inflammatory bowel disease and the risk of surgery for non-neoplastic bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2007, v. 25, n. 12, p. 1435, doi. 10.1111/j.1365-2036.2007.03341.x
- By:
- Publication type:
- Article
Review article: biological activity markers in inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2007, v. 25, n. 3, p. 247, doi. 10.1111/j.1365-2036.2006.03184.x
- By:
- Publication type:
- Article
Systematic review: the management of pouchitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2006, v. 23, n. 8, p. 1087, doi. 10.1111/j.1365-2036.2006.02884.x
- By:
- Publication type:
- Article
CDP571, a humanized monoclonal antibody to tumour necrosis factor-α, for steroid-dependent Crohn's disease: a randomized, double-blind, placebo-controlled trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2006, v. 23, n. 5, p. 617, doi. 10.1111/j.1365-2036.2006.02791.x
- By:
- Publication type:
- Article
Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 6, p. 733, doi. 10.1111/j.1365-2036.2005.02405.x
- By:
- Publication type:
- Article
A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-α, in patients with corticosteroid-dependent Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 4, p. 373, doi. 10.1111/j.1365-2036.2005.02336.x
- By:
- Publication type:
- Article
Budesonide as maintenance treatment in Crohn's disease: a placebo-controlled trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2005, v. 21, n. 4, p. 363, doi. 10.1111/j.1365-2036.2005.02338.x
- By:
- Publication type:
- Article
Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2004, v. 19, n. 10, p. 1089, doi. 10.1111/j.1365-2036.2004.01964.x
- By:
- Publication type:
- Article
Mild to moderate Crohn's disease – defining the basis for a new treatment algorithm.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 18, n. 3, p. 263, doi. 10.1046/j.1365-2036.2003.01661.x
- By:
- Publication type:
- Article
Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 17, n. 11, p. 1355, doi. 10.1046/j.1365-2036.2003.01589.x
- By:
- Publication type:
- Article
The pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2003, v. 17, n. 1, p. 29, doi. 10.1046/j.1365-2036.2003.01408.x
- By:
- Publication type:
- Article
Systematic review: the effectiveness of budesonide therapy for Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2002, v. 16, n. 8, p. 1509, doi. 10.1046/j.1365-2036.2002.01289.x
- By:
- Publication type:
- Article
The epidemiology and natural history of Crohn’s disease in population-based patient cohorts from North America: a systematic review.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2002, v. 16, n. 1, p. 51, doi. 10.1046/j.1365-2036.2002.01140.x
- By:
- Publication type:
- Article
Colonic motility in chronic ulcerative proctosigmoiditis and the effects of nicotine on colonic motility in patients and healthy subjects.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2001, v. 15, n. 5, p. 653, doi. 10.1046/j.1365-2036.2001.00959.x
- By:
- Publication type:
- Article
Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double-blind, placebo-controlled trial.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1997, v. 11, n. 6, p. 1041, doi. 10.1046/j.1365-2036.1997.00253.x
- By:
- Publication type:
- Article
A dose-ranging pharmacokinetic study of nicotine tartrate following single-dose delayed-release oral and intravenous administration.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1997, v. 11, n. 5, p. 865, doi. 10.1046/j.1365-2036.1997.00236.x
- By:
- Publication type:
- Article
Nicotine enemas for active ulcerative colitis-a pilot study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1997, v. 11, n. 5, p. 859, doi. 10.1046/j.1365-2036.1997.00220.x
- By:
- Publication type:
- Article
Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 1997, v. 11, n. 4, p. 663, doi. 10.1046/j.1365-2036.1997.00208.x
- By:
- Publication type:
- Article
CT enterography and fistulizing Crohn's disease: clinical benefit and radiographic findings.
- Published in:
- 2009
- By:
- Publication type:
- journal article
An expert consensus to standardise definitions, diagnosis and treatment targets for anti‐fibrotic stricture therapies in Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 3, p. 347, doi. 10.1111/apt.14853
- By:
- Publication type:
- Article
Systematic review and network meta‐analysis: first‐ and second‐line biologic therapies for moderate‐severe Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 4, p. 394, doi. 10.1111/apt.14852
- By:
- Publication type:
- Article
Long‐term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 48, n. 1, p. 65, doi. 10.1111/apt.14794
- By:
- Publication type:
- Article
Systematic review with meta‐analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 12, p. 1578, doi. 10.1111/apt.14672
- By:
- Publication type:
- Article
High body mass index is associated with increased risk of treatment failure and surgery in biologic‐treated patients with ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 11, p. 1472, doi. 10.1111/apt.14665
- By:
- Publication type:
- Article
Reliability of histologic assessment in patients with eosinophilic oesophagitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 7, p. 940, doi. 10.1111/apt.14559
- By:
- Publication type:
- Article
Physicians’ perspective on the clinical meaningfulness of inflammatory bowel disease trial results: an International Organization for the Study of Inflammatory Bowel Disease (IOIBD) survey.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 6, p. 773, doi. 10.1111/apt.14514
- By:
- Publication type:
- Article
Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 219, doi. 10.1111/apt.14420
- By:
- Publication type:
- Article
Exposure-response relationship of certolizumab pegol induction and maintenance therapy in patients with Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 229, doi. 10.1111/apt.14421
- By:
- Publication type:
- Article
Systematic review with network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 2, p. 162, doi. 10.1111/apt.14422
- By:
- Publication type:
- Article
The development of a magnetic resonance imaging index for fistulising Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 5, p. 516, doi. 10.1111/apt.14190
- By:
- Publication type:
- Article
Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 3, p. 292, doi. 10.1111/apt.14164
- By:
- Publication type:
- Article
Review article: moving towards common therapeutic goals in Crohn's disease and rheumatoid arthritis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 8, p. 1058, doi. 10.1111/apt.13995
- By:
- Publication type:
- Article
Review article: dose optimisation of infliximab for acute severe ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 5, p. 617, doi. 10.1111/apt.13913
- By:
- Publication type:
- Article
Systematic review with meta-analysis: recurrence of Crohn's disease after total colectomy with permanent ileostomy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 3, p. 381, doi. 10.1111/apt.13886
- By:
- Publication type:
- Article
Effects of concomitant immunomodulators on the pharmacokinetics, efficacy and safety of adalimumab in patients with Crohn's disease or ulcerative colitis who had failed conventional therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 45, n. 1, p. 50, doi. 10.1111/apt.13838
- By:
- Publication type:
- Article
Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2016, v. 44, n. 2, p. 157, doi. 10.1111/apt.13653
- By:
- Publication type:
- Article